N-Myc Downstream-Regulated Gene 4 ( NDRG4 ): A Candidate Tumor Suppressor Gene and Potential Biomarker for Colorectal Cancer

Veerle Melotte, Marjolein H.F.M. Lentjes, Sandra M. van den Bosch, +16

JNCI Journal of the National Cancer Institute

GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer

Debby M.E.I. Hellebrekers, Marjolein H.F.M. Lentjes, Sandra M. van den Bosch, +17

Clinical Cancer Research

The CpG Island Methylator Phenotype: What's in a Name?

Laura Hughes, Veerle Melotte, Joachim De Schrijver, +12

Cancer Research

Identification of Epigenetically Silenced Genes in Tumor Endothelial Cells

Debby M.E.I. Hellebrekers, Veerle Melotte, Emmanuelle Viré, +7

Cancer Research

Histone ModificationsEndothelial CellsEpigenetic ChangeTumor Endothelial CellsCancer Biology +15

Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population

Linda J.W. Bosch, Veerle Melotte, Sandra Mongera, +15

The American Journal of Gastroenterology

Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study

Lindsay C. Hewitt, Imran Inam, Yuichi Saito, +12

European Journal of Cancer

A Four-Gene Promoter Methylation Marker Panel Consisting of <i>GREM1, NEURL, LAD1,</i> and <i>NEFH</i> Predicts Survival of Clear Cell Renal Cell Cancer Patients

Iris J.H. van Vlodrop, Sophie C. Joosten, Tim De Meyer, +15

Clinical Cancer Research

DNA Methylation of Phosphatase and Actin Regulator 3 Detects Colorectal Cancer in Stool and Complements FIT

Linda J.W. Bosch, Frank A. Oort, Maarten Neerincx, +14

Cancer Prevention Research

Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening

Iris Lansdorp‐Vogelaar, S. Lucas Goede, Linda J.W. Bosch, +6

Clinical Gastroenterology and Hepatology

Biomarker (Medicine)Fecal Immunochemical TestOncologyNoninvasive Colorectal CancerCancer Detection +11

Loss of enteric neuronal <i>Ndrg4</i> promotes colorectal cancer via increased release of Nid1 and Fbln2

Nathalie Vaes, Simone L. Schonkeren, Glenn Rademakers, +19

EMBO Reports